Everolimus induced pneumonitis in a lung transplant recipient

Everolimus is a mechanistic target of rapamycin inhibitor used for the treatment of various cancers and prevention of allograft rejection in solid organ transplantation. We present a case of a lung transplant recipient on everolimus who was admitted with generalized weakness, hypoxia and new onset b...

Descripción completa

Detalles Bibliográficos
Autores principales: Arunachalam, Ambalavanan, Ali, Syed Rizwan, Wakefield, Brett J, Lane, Charles R, Mehta, Atul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915951/
https://www.ncbi.nlm.nih.gov/pubmed/29713487
http://dx.doi.org/10.1093/omcr/omy008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915951/
https://www.ncbi.nlm.nih.gov/pubmed/29713487
http://dx.doi.org/10.1093/omcr/omy008

Ejemplares similares